| Primary |
| Gastrooesophageal Reflux Disease |
14.3% |
| Dyspepsia |
10.2% |
| Abdominal Pain Upper |
8.2% |
| Aortic Aneurysm |
6.1% |
| Atrial Fibrillation |
6.1% |
| Coronary Artery Disease |
6.1% |
| Gastritis |
6.1% |
| Myocardial Ischaemia |
6.1% |
| Prophylaxis |
6.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.1% |
| Anxiety |
4.1% |
| Prophylaxis Of Neural Tube Defect |
4.1% |
| Abdominal Discomfort |
2.0% |
| Depression |
2.0% |
| Diaphragmatic Hernia |
2.0% |
| Gastrointestinal Disorder |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Hypertension |
2.0% |
| Hypoparathyroidism |
2.0% |
| Oedema |
2.0% |
|
| Hypomagnesaemia |
16.0% |
| Patent Ductus Arteriosus |
8.0% |
| Tetany |
8.0% |
| Cutaneous Lupus Erythematosus |
4.0% |
| Drug Administration Error |
4.0% |
| Drug Hypersensitivity |
4.0% |
| Hypophosphataemia |
4.0% |
| Hypotonia Neonatal |
4.0% |
| Muscle Spasms |
4.0% |
| Paraesthesia |
4.0% |
| Polyneuropathy |
4.0% |
| Pruritus |
4.0% |
| Psychomotor Retardation |
4.0% |
| Rash |
4.0% |
| Renal Failure |
4.0% |
| Respiratory Distress |
4.0% |
| Tachycardia |
4.0% |
| Thrombocytopenia |
4.0% |
| Thrombosis In Device |
4.0% |
| Transient Ischaemic Attack |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
17.3% |
| Drug Use For Unknown Indication |
15.6% |
| Hypertension |
10.6% |
| Neuralgia |
6.7% |
| Dyspepsia |
5.6% |
| Gastrooesophageal Reflux Disease |
5.0% |
| Myocardial Ischaemia |
5.0% |
| Breast Cancer |
4.5% |
| Prophylaxis |
4.5% |
| Abdominal Discomfort |
3.9% |
| Atrial Fibrillation |
2.8% |
| Helicobacter Infection |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Immune Thrombocytopenic Purpura |
2.2% |
| Lung Neoplasm Malignant |
2.2% |
| Rheumatoid Arthritis |
2.2% |
| Staphylococcal Bacteraemia |
2.2% |
| Abdominal Pain Upper |
1.7% |
| Anaesthesia |
1.7% |
| Breast Cancer Female |
1.7% |
|
| Vomiting |
12.5% |
| Gastrooesophageal Reflux Disease |
7.5% |
| Suicide Attempt |
7.5% |
| Deep Vein Thrombosis |
5.0% |
| Diabetes Mellitus |
5.0% |
| Gastrointestinal Disorder |
5.0% |
| Myocardial Infarction |
5.0% |
| Pain In Extremity |
5.0% |
| Patent Ductus Arteriosus |
5.0% |
| Rash Generalised |
5.0% |
| Skin Exfoliation |
5.0% |
| Syncope |
5.0% |
| Tachycardia |
5.0% |
| Toxic Epidermal Necrolysis |
5.0% |
| Withdrawal Syndrome |
5.0% |
| Coma |
2.5% |
| Completed Suicide |
2.5% |
| Drug Administration Error |
2.5% |
| Gout |
2.5% |
| Gynaecomastia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.1% |
| Drug Use For Unknown Indication |
13.8% |
| Hypertension |
12.1% |
| Rheumatoid Arthritis |
9.9% |
| Prophylaxis |
7.1% |
| Pain |
6.6% |
| Osteoporosis |
5.0% |
| Depression |
3.7% |
| Diabetes Mellitus |
2.9% |
| Gastritis |
2.8% |
| Type 2 Diabetes Mellitus |
2.0% |
| Atrial Fibrillation |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Prostate Cancer |
1.8% |
| Gastric Disorder |
1.8% |
| Insomnia |
1.6% |
| Breast Cancer |
1.5% |
| Renal Transplant |
1.4% |
| Non-small Cell Lung Cancer |
1.3% |
| Gastric Cancer |
1.2% |
|
| Vomiting |
13.6% |
| Pyrexia |
10.8% |
| Weight Decreased |
10.5% |
| Urinary Tract Infection |
6.8% |
| Death |
5.1% |
| Pain In Extremity |
4.5% |
| Renal Failure |
4.2% |
| Sepsis |
4.2% |
| Thrombocytopenia |
4.2% |
| Pulmonary Embolism |
4.0% |
| Renal Failure Acute |
3.7% |
| Renal Impairment |
3.7% |
| Syncope |
3.7% |
| Respiratory Failure |
3.4% |
| Diarrhoea |
3.1% |
| Pneumonia |
3.1% |
| Rhabdomyolysis |
3.1% |
| Rash |
2.8% |
| Tachycardia |
2.8% |
| Myocardial Infarction |
2.5% |
|
| Interacting |
| Hypertension |
15.5% |
| Gastritis |
8.5% |
| Gastrooesophageal Reflux Disease |
8.5% |
| Gouty Arthritis |
8.5% |
| Atrial Fibrillation |
5.6% |
| Coronary Artery Disease |
5.6% |
| Depression |
5.6% |
| Pain |
5.6% |
| Helicobacter Gastritis |
4.2% |
| Oedema |
4.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.2% |
| Renal Failure Chronic |
4.2% |
| Tachyarrhythmia |
4.2% |
| Endocarditis Bacterial |
2.8% |
| Gouty Tophus |
2.8% |
| Myocardial Ischaemia |
2.8% |
| Procedural Nausea |
2.8% |
| Abdominal Pain Upper |
1.4% |
| Dyspepsia |
1.4% |
| Hyperlipidaemia |
1.4% |
|
| Drug Interaction |
50.0% |
| Renal Failure |
25.0% |
| Clostridium Difficile Colitis |
8.3% |
| Gout |
8.3% |
| Thrombosis In Device |
8.3% |
|
